O
KNTE
OrbiMed’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,009,729
| Closed | -$21.3M | – | 122 |
|
|
2024
Q1 | $21.3M | Hold |
8,009,729
| – | – | 0.39% | 61 |
|
|
2023
Q4 | $19M | Hold |
8,009,729
| – | – | 0.38% | 63 |
|
|
2023
Q3 | $11.2M | Hold |
8,009,729
| – | – | 0.24% | 79 |
|
|
2023
Q2 | $24.3M | Buy |
8,009,729
+2,866,100
| +56% | +$8.68M | 0.44% | 62 |
|
|
2023
Q1 | $32.1M | Buy |
5,143,629
+1,100,000
| +27% | +$6.88M | 0.63% | 52 |
|
|
2022
Q4 | $24.7M | Hold |
4,043,629
| – | – | 0.47% | 62 |
|
|
2022
Q3 | $48.3K | Hold |
4,043,629
| – | – | 0.9% | 42 |
|
|
2022
Q2 | $51K | Hold |
4,043,629
| – | – | 0.92% | 36 |
|
|
2022
Q1 | $45.5M | Buy |
4,043,629
+195,700
| +5% | +$2.2M | 0.74% | 42 |
|
|
2021
Q4 | $68.2M | Hold |
3,847,929
| – | – | 0.88% | 40 |
|
|
2021
Q3 | $88.6M | Hold |
3,847,929
| – | – | 0.97% | 29 |
|
|
2021
Q2 | $89.6M | Hold |
3,847,929
| – | – | 0.91% | 35 |
|
|
2021
Q1 | $120M | Hold |
3,847,929
| – | – | 1.12% | 27 |
|
|
2020
Q4 | $153M | Buy |
+3,847,929
| New | +$153M | 1.34% | 19 |
|